Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Form 8.5 (EPT/RI) Martson's Plc - Amendment

8 Feb 2021 10:00

RNS Number : 3070O
Peel Hunt LLP
08 February 2021
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

Form 8.5 (EPT/RI) - Marston's Plc announcement released on 05/02/2021 at 12:00 under RNS No 1575O has been amended.

 

Amendments are identified with an asterisk (*).

 

The full amended text is shown below.

 

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Marston's Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Marston's Plc

(d) Date dealing undertaken:

04 February 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Buy

1,132,406*

96.78 GBx

93.65 GBx

Ordinary Shares

Sell

1,144,744

96.79 GBx

94.18 GBx

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

08 February 2021

 

Contact name:

Kathleen Lloyd

Telephone number:

0207 418 8911

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERBGGDDGGGDGBI
Date   Source Headline
28th Jan 20113:23 pmRNSResult of AGM
28th Jan 20117:00 amRNSAGM and Interim Management Statement
11th Jan 20115:31 pmRNSBlocklisting Interim Review
4th Jan 20117:00 amRNSTotal Voting Rights
20th Dec 20105:12 pmRNSAnnual Financial Report
20th Dec 201010:34 amRNSAnnual Information Update
2nd Dec 20107:00 amRNSPreliminary Results
30th Nov 20101:37 pmRNSTotal Voting Rights
29th Nov 20104:03 pmRNSHolding(s) in Company
26th Nov 20103:33 pmRNSNeil Goulden Appointed Chairman of Audit Committee
29th Oct 201011:51 amRNSTotal Voting Rights
6th Oct 20107:00 amRNSTrading Statement
30th Sep 20109:56 amRNSTotal Voting Rights
28th Sep 201011:17 amRNSBlocklisting Interim Review
1st Sep 201012:56 pmRNSNotice of Forthcoming Events
31st Aug 20104:15 pmRNSTotal Voting Rights
23rd Aug 201011:37 amRNSDirector/PDMR Shareholding
19th Aug 20107:00 amRNSAppointment of Non Executive Director
4th Aug 20107:00 amRNSInterim Management Statement
30th Jul 201011:13 amRNSTotal Voting Rights
5th Jul 20102:49 pmRNSHolding(s) in Company
2nd Jul 201010:50 amRNSDirector/PDMR Shareholding
1st Jul 20109:03 amRNSTotal Voting Rights
28th Jun 20103:39 pmRNSDirector/PDMR Shareholding
24th Jun 20107:00 amRNSAnalyst Visit
21st Jun 20109:40 amRNSNotice of Interim Management Statement
1st Jun 20109:18 amRNSTotal Voting Rights
25th May 20102:44 pmRNSDirector/PDMR Shareholding
21st May 20108:55 amRNSDirector/PDMR Shareholding
20th May 20107:00 amRNSInterim Results
30th Apr 201011:36 amRNSTotal Voting Rights
7th Apr 20107:00 amRNSTrading Statement
31st Mar 20104:23 pmRNSTotal Voting Rights
25th Mar 20107:15 amRNSAppointment Of Joint Broker
26th Feb 20102:39 pmRNSTotal Voting Rights
19th Feb 20107:00 amRNSNotice of Trading Update
8th Feb 20102:00 pmRNSDirector/PDMR Shareholding
3rd Feb 201012:56 pmRNSDirector/PDMR Shareholding
1st Feb 20107:00 amRNSNotice of Results
29th Jan 20104:39 pmRNSResult of AGM
29th Jan 20107:00 amRNSAGM and Interim Management Statement
28th Jan 201010:14 amRNSTotal Voting Rights
11th Jan 201010:50 amRNSDisclosure of charges over shares by PDMR
5th Jan 20109:49 amRNSTotal Voting Rights
21st Dec 20094:05 pmRNSAnnual Financial Report
18th Dec 20093:10 pmRNSAnnual Information Update
10th Dec 200910:00 amRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSFinal Results
19th Nov 20091:10 pmRNSDirector/PDMR Shareholding
29th Oct 20093:44 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.